Skip to main content
SpringerLink
Log in

Tetramethylpyrazine alleviated cytokine synthesis and dopamine deficit and improved motor dysfunction in the mice model of Parkinson’s disease

  • Original Article
  • Published:
Neurological Sciences Aims and scope Submit manuscript

Abstract

It was previously reported that cytokines and neurotoxins released from activated inflammatory cells induced the loss of projecting dopaminergic neurons in the substantia nigra, which triggered the pathogenesis of PD. The present study investigated the effect of treatment with tetramethylpyrazine (TMP) on the central cytokine synthesis, striatal dopamine content and glutamatergic transmission, and behavioral performance in the rotarod task in mice injected with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Treatment with TMP significantly improved the behavioral performance in the rotarod task in mice injected with MPTP. It also decreased the upregulation of cytokines (tumor necrosis factor-α and interleukin-1β) in the substantia nigra and striatum in these modeled mice. Furthermore, treatment with TMP significantly improved the dopamine deficits and attenuated the upregulation of striatal basal glutamatergic strength in the striatum of mice injected with MPTP. These results indicated that TMP might serve as a novel approach for the treatment of patients with PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Bagetta V, Ghiglieri V, Sgobio C, Calabresi P, Picconi B (2010) Synaptic dysfunction in Parkinson’s disease. Biochem Soc Trans 38:493–497

    Article  CAS  PubMed  Google Scholar 

  2. Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B (2010) Levodopa-induced dyskinesias in patients with Parkinson’s disease: filling the bench-to-bedside gap. Lancet Neurol 9:1106–1117

    Article  CAS  PubMed  Google Scholar 

  3. Liu SJ, Zukin RS (2007) Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci 30:126–134

    Article  CAS  PubMed  Google Scholar 

  4. Bagetta V, Sgobio C, Pendolino V, Del Papa G, Tozzi A et al (2012) Rebalance of striatal NMDA/AMPA receptor ratio underlies the reduced emergence of dyskinesia during D2-like dopamine agonist treatment in experimental Parkinson’s disease. J Neurosci 32:17921–17931

    Article  CAS  PubMed  Google Scholar 

  5. Fan L, Wang K, Shi Z, Die J, Wang C et al (2011) Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia–reperfusion injury. J Vasc Surg 54:192–200

    Article  PubMed  Google Scholar 

  6. Wu HJ, Hao J, Wang SQ, Jin BL, Chen XB (2012) Protective effects of ligustrazine on TNF-alpha-induced endothelial dysfunction. Eur J Pharmacol 674:365–369

    Article  CAS  PubMed  Google Scholar 

  7. Wang DQ, Wang W, Jing FC (2007) Effects of tetramethylpyrazine on brain oxidative damage induced by intracerebral perfusion of L-DOPA in rats with Parkinson’s disease. Zhongguo Zhong Xi Yi Jie He Za Zhi 27:629–632

    PubMed  Google Scholar 

  8. Niranjan R (2013) The role of inflammatory and oxidative stress mechanisms in the pathogenesis of Parkinson’s disease: focus on astrocytes. Mol Neurobiol 49:28–38

    Article  PubMed  Google Scholar 

  9. Borrajo A, Rodriguez-Perez AI, Diaz-Ruiz C, Guerra MJ, Labandeira-Garcia JL (2014) Microglial TNF-alpha mediates enhancement of dopaminergic degeneration by brain angiotensin. Glia 62:145–157

    Article  PubMed  Google Scholar 

  10. Kurkowska-Jastrzebska I, Wronska A, Kohutnicka M, Czlonkowski A, Czlonkowska A (1999) The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse. Exp Neurol 156:50–61

    Article  CAS  PubMed  Google Scholar 

  11. Chung YC, Bok E, Huh SH, Park JY, Yoon SH et al (2011) Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation. J Immunol 187:6508–6517

    Article  CAS  PubMed  Google Scholar 

  12. Li F, Zhu S, Wu C, Yan C, Liu Y et al (2011) Neuroinflammation and cell therapy for Parkinson’s disease. Front Biosci (Schol Ed) 3:1407–1420

    Article  Google Scholar 

  13. Liu J, Qiang W, Ye S (1995) Effect of tetramethylpyrazine on lymphocytes proliferation response of murine splenocytes. Hua Xi Yi Ke Da Xue Xue Bao 26:177–179

    CAS  PubMed  Google Scholar 

  14. Che XW, Zhang Y, Wang H, Wang W (2008) Effect of ligustrazine injection on levels of interleukin-4 and interferon-gamma in patients with bronchial asthma. Chin J Integr Med 14:217–220

    Article  CAS  PubMed  Google Scholar 

  15. Shin JW, Moon JY, Seong JW, Song SH, Cheong YJ et al (2013) Effects of tetramethylpyrazine on microglia activation in spinal cord compression injury of mice. Am J Chin Med 41:1361–1376

    Article  CAS  PubMed  Google Scholar 

  16. Kao TK, Chang CY, Ou YC, Chen WY, Kuan YH et al (2013) Tetramethylpyrazine reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. Exp Neurol 247:188–201

    Article  CAS  PubMed  Google Scholar 

  17. Neve KA, Seamans JK, Trantham-Davidson H (2004) Dopamine receptor signaling. J Recept Signal Transduct Res 24:165–205

    Article  CAS  PubMed  Google Scholar 

  18. Koutsokera M, Kafkalias P, Giompres P, Kouvelas ED, Mitsacos A (2014) Expression and phosphorylation of glutamate receptor subunits and CaMKII in a mouse model of Parkinsonism. Brain Res 1549:22–31

    Article  CAS  PubMed  Google Scholar 

  19. Azdad K, Chavez M, Don Bischop P, Wetzelaer P, Marescau B et al (2009) Homeostatic plasticity of striatal neurons intrinsic excitability following dopamine depletion. PLoS ONE 4:e6908

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, The Fourth Affiliated Hospital of Harbin Medical University, 37 Yiyuan Street, Harbin, 150001, Heilongjiang, China

    Hong Zhao, Mei-Ling Xu, Qi Zhang, Zhao-Hui Guo, Ying Peng, Zheng-Yi Qu & Yong-Nan Li

Authors
  1. Hong Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mei-Ling Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qi Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhao-Hui Guo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ying Peng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zheng-Yi Qu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yong-Nan Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hong Zhao.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhao, H., Xu, ML., Zhang, Q. et al. Tetramethylpyrazine alleviated cytokine synthesis and dopamine deficit and improved motor dysfunction in the mice model of Parkinson’s disease. Neurol Sci 35, 1963–1967 (2014). https://doi.org/10.1007/s10072-014-1871-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1871-9

Keywords

Search

Navigation